Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ITC tadalafil investigation

Executive Summary

International Trade Commission launches investigation into a complaint filed by Lilly ICOS seeking an order barring importation or marketing in the U.S. of tadalafil that infringes its U.S. patent 5,859,006 for Cialis, the commission says May 16. The complaint names 10 Internet marketers of the infringing product. The '006 patent expires in January 2016, according to the Orange Book. Lilly notes it has not been able to discover any producers of unapproved generic tadalafil in the U.S. The ITC expects to hold a hearing on the investigation in early fall...

You may also be interested in...



US FDA Connects Dots For Drug Manufacturers’ Responses To CRLs With Draft Guidance

CRLs FDA submits in response to ANDAs increased most years since FY 2015, though FY 2020 total likely will be lower than two previous years. A 2019 CRL interrupted GSK's plans to market first mouth spray nicotine replacement therapy in US.

Inovio COVID-19 Vaccine Trial Delayed By FDA Partial Hold

The US FDA appears to have concerns about the device used to administer the vaccine.

US Lab-Testing Certification Process Will Be Streamlined Under Quick-Start Guide, CMS Says

The US Medicare agency has released a quick-start guide for laboratory certification.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel